Our Mission

Established in 2013, the Oklahoma Clinical and Translational Science Institute serves as a catalyst for clinical and translational research that improves health and healthcare for Oklahomans, to provide training and infrastructure to help junior investigators to launch independent research careers, and to expand the opportunities of IDeA states and Oklahoma communities to participate in research that improves the health of our residents. 

Oklahoma Shared Clinical and Translational Resources

OSCTR is Oklahoma's NIH-funded IDeA-CTR that provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in the state

Oklahoma Primary Healthcare Improvement Cooperative

 

OPHIC is the implementation science arm of a statewide network to help improve healthcare delivery assisting primary care practices to adopt evidence-based best practices for the care of their patients.

OCTSI Clinical Research Unit

​​

The OCTSI CRU assists medical providers to identify and conduct clinical research opportunities in Oklahoma.

Translating Practice into Research Program RFA

This year the OSCTR is starting a research training program.

Translating Practice into Research (TPIR), for healthcare professionals, clinical investigators, and basic scientists funded by the NIH Oklahoma Shared Clinical and Translational Resources grant. The goal of the TPIR trainee program is to produce a group of clinicians and scientists who have the ability to translate their clinical observations and ideas for improving practice into practical and feasible research projects. Attached is a detailed description. 

Presbyterian Health Foundation Seed and Bridge Grants

Presbyterian Health Foundation has graciously agreed to provide significant funds for seed and bridge grants for OUHC faculty members. 

ELIGIBILITY: Limited to OUHC faculty

DEADLINE: June 27, 2014 with an anticipated start date of October 1, 2014. 

Details about the program scope, submission process, eligibility, application guidelines and funding information are found in the attached announcements.

Seed grants

Subscribe to News

Recent Publications

Multi-level determinants of vaccination of the American Indian and Alaska Native population: a comprehensive overview

Front Public Health. 2025 Feb 18;13:1490286. doi: 10.3389/fpubh.2025.1490286. eCollection 2025.

ABSTRACT

CONTEXT: American Indians and Alaska Natives (AIANs) are historically disadvantaged, losing 20 million (95%) of their population largely through epidemics since 1,520 and continuing lower overall vaccination coverage than other races. Determinants of this lower coverage are underexamined.

Effect of Early and Delayed Treatment With Remdesivir on Mortality in Patients Hospitalized With COVID-19

Open Forum Infect Dis. 2025 Feb 27;12(2):ofae740. doi: 10.1093/ofid/ofae740. eCollection 2025 Feb.

ABSTRACT

BACKGROUND: We applied a target trial emulation framework to estimate the association between early and delayed initiation of remdesivir (RDV) with mortality in hospitalized adults between May 1, 2020, and July 31, 2024, with varying coronavirus disease 2019 (COVID-19) clinical severity.

Media